Disease is an infectious disease, caused as a result of bacterium –Borrelia burgdorferi, which is transmitted to humans through bites ofinfected adult black-legged ticks. Most human infections are as aresult of bites of nymphs (immature tick). Ticks can put on any partof the human body and can transmit the infection, if attached to thehost body for 36 to 48 hours. Blacklegged ticks are accountable forspreading Lyme disease in the northeastern, mid-Atlantic, andnorth-central aspects of the U.S. However, western black-legged ticksspread Lyme disease in the regions over the Pacific Coast. Theseregions are thus, anticipated to witness rapid growth of industry forLyme disease treatment in the near future.
The major players operating in the LymeDisease Treatment Market include Lupin Ltd, Mylan N.V.,Sun Pharmaceuticals Industries Ltd., Pfizer Inc., G&WLaboratories, Inc., Teva Pharmaceutical Industries Ltd., Sandoz AG,GlaxoSmithKline plc., and Hospira Inc.
Antibiotics are found to be the utmost effective treatment forLyme disease. Patients with early stages of Lyme disease recoverrapidly and completely with appropriate antibiotics such as as anexample doxycycline, amoxicillin, and cefuroxime axetil. Patientswith certain neurological or cardiac illness could be treated withintravenous ceftriaxone. Patients bearing chronic symptoms of Lymedisease for over 6 months, can recover within a few weeks, throughoral antibiotic treatment.
Read More@https://bit.ly/388oVuN
